UY34170A - Formas cristalinas de 2,2,2-trifluoro-N-[(1R,2S)-1-[1-(4-fluorofenil)indazol-5-il]oxi-1-(3-metoxifenil)propan-2-il]acetamida - Google Patents

Formas cristalinas de 2,2,2-trifluoro-N-[(1R,2S)-1-[1-(4-fluorofenil)indazol-5-il]oxi-1-(3-metoxifenil)propan-2-il]acetamida

Info

Publication number
UY34170A
UY34170A UY0001034170A UY34170A UY34170A UY 34170 A UY34170 A UY 34170A UY 0001034170 A UY0001034170 A UY 0001034170A UY 34170 A UY34170 A UY 34170A UY 34170 A UY34170 A UY 34170A
Authority
UY
Uruguay
Prior art keywords
indazol
propan
trifluoro
acetamide
fluorophenyl
Prior art date
Application number
UY0001034170A
Other languages
English (en)
Spanish (es)
Inventor
Helena Ingemo Andersson
Kelly Yvonne Conway
Michael John Quayle
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of UY34170A publication Critical patent/UY34170A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
UY0001034170A 2011-06-29 2012-06-28 Formas cristalinas de 2,2,2-trifluoro-N-[(1R,2S)-1-[1-(4-fluorofenil)indazol-5-il]oxi-1-(3-metoxifenil)propan-2-il]acetamida UY34170A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161502656P 2011-06-29 2011-06-29

Publications (1)

Publication Number Publication Date
UY34170A true UY34170A (es) 2013-01-31

Family

ID=46420454

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001034170A UY34170A (es) 2011-06-29 2012-06-28 Formas cristalinas de 2,2,2-trifluoro-N-[(1R,2S)-1-[1-(4-fluorofenil)indazol-5-il]oxi-1-(3-metoxifenil)propan-2-il]acetamida

Country Status (16)

Country Link
EP (1) EP2726464A1 (zh)
JP (1) JP2014527955A (zh)
KR (1) KR20140036230A (zh)
CN (1) CN103814015A (zh)
AR (1) AR086818A1 (zh)
AU (1) AU2012277514A1 (zh)
BR (1) BR112013031759A2 (zh)
CA (1) CA2839398A1 (zh)
IN (1) IN2014MN00023A (zh)
MX (1) MX2013014566A (zh)
RU (1) RU2013153466A (zh)
SG (1) SG195309A1 (zh)
TW (1) TW201305115A (zh)
UY (1) UY34170A (zh)
WO (1) WO2013001294A1 (zh)
ZA (1) ZA201309480B (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017161518A1 (en) 2016-03-23 2017-09-28 Astrazeneca Ab New physical form
CN108314670B (zh) * 2018-02-06 2020-04-07 江苏八巨药业有限公司 一种(s)-2-氯-1-(6-氟-1-苯并二氢吡喃-2-基)-乙醇的制备方法
WO2022114105A1 (ja) * 2020-11-27 2022-06-02 ミライラボバイオサイエンス株式会社 高純度βニコチンアミドモノヌクレオチド（ＮＭＮ）及びその製造方法
KR102571432B1 (ko) * 2023-02-08 2023-08-29 주식회사 에스씨엘테라퓨틱스 인다졸릴에스테르 및 아미드 유도체를 포함하는 암 치료용 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302777D0 (sv) 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
SE9101090D0 (sv) 1991-04-11 1991-04-11 Astra Ab Process for conditioning of water-soluble substances
GB0315509D0 (en) 2003-07-02 2003-08-06 Meridica Ltd Dispensing device
JO2754B1 (en) 2006-12-21 2014-03-15 استرازينكا ايه بي Amylendazoleil derivatives for the treatment of glucocorticoid-mediated disorders
WO2008079073A1 (en) 2006-12-22 2008-07-03 Astrazeneca Ab Indazolyl sulphonamide derivatives for the treatment of glucocorticoid receptor mediated disorders
ES2535979T3 (es) 2010-07-21 2015-05-19 Astrazeneca Ab Inhalador
CN103118727B (zh) 2010-07-21 2015-11-25 阿斯利康(瑞典)有限公司 吸入器

Also Published As

Publication number Publication date
CN103814015A (zh) 2014-05-21
EP2726464A1 (en) 2014-05-07
CA2839398A1 (en) 2013-01-03
WO2013001294A1 (en) 2013-01-03
SG195309A1 (en) 2013-12-30
KR20140036230A (ko) 2014-03-25
RU2013153466A (ru) 2015-08-10
TW201305115A (zh) 2013-02-01
BR112013031759A2 (pt) 2016-12-13
AU2012277514A1 (en) 2014-01-09
ZA201309480B (en) 2015-10-28
JP2014527955A (ja) 2014-10-23
AR086818A1 (es) 2014-01-22
IN2014MN00023A (zh) 2015-06-12
MX2013014566A (es) 2014-09-25

Similar Documents

Publication Publication Date Title
CY1121129T1 (el) Αναστολεις toy fgfr4 πυριμιδινης
UY34559A (es) Inhibidores de bromodominios
UY34515A (es) Triazolopiridinas sustituidas
UY34374A (es) Benzilindazoles sustituidos
CL2012000590A1 (es) Proceso para preparar w-transaminasa (r)-selectiva.
UY34765A (es) Compuestos novedosos.
UY34502A (es) Arilos y heteroarilos bicíclicos inhibidores de los canales de sodio
UY34039A (es) Compuestos fungicidas
UY34156A (es) Compuestos inhibidores de metaloenzimas
UY34824A (es) Nucleósidos de espirooxetano de uracilo
UY33925A (es) Inhibidores tricíclicos de quinasas
UY34034A (es) Triazolopiridinas
UY34632A (es) Compuestos de oxazolidin- 2- ona y usos de los mismos
UY33978A (es) Piridinonas bicíclicas nuevas.
UY34210A (es) Composiciones, métodos y sistemas para la micropropagación de plantas
UY34318A (es) ?derivados de isotiazolina útiles como compuestos insecticidas?
ECSP14013251A (es) Derivados de 5-flúor-4-imino-3-(sustituido)-3,4-dihidropirimidin-2(1h)ona
UY34467A (es) Procedimiento para la preparación de 5-fluoro-1h-pirazolopiridinas sustituidas
UY34006A (es) Imidazopiridazinas
CL2012002082A1 (es) Proceso para la preparacion de lacosamida, por hidroximetilación; compuestos intermediarios.
UY34329A (es) Compuestos de triazolopiridina
UY33976A (es) Derivados de pirazolo-pirimidina.
UY34158A (es) Composicion herbicida
UY34553A (es) Procedimiento de preparación de la sal de l-arginina de perindoprilo
UY34791A (es) N-etil-4-hidroxil-1-metil-5-(metil(2,3,4,5,6-pentahidroxihexil)amino)-2-oxo-n-fenil-1,2- dihidroquinolina-3-carboxamida

Legal Events

Date Code Title Description
RDES Application refused

Effective date: 20211015